sb 216763 has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anikina, LV; Babkov, DA; Bezsonova, EN; Borisov, AV; Efremov, AM; Lozinskaya, NA; Perfilova, VN; Proskurnina, MV; Spasov, AA; Tsymlyakov, MD; Tyurenkov, IN; Zakharyascheva, OY; Zaryanova, EV | 1 |
| Datusalia, AK; Sharma, SS | 1 |
| Cao, YY; Chen, QL; Fang, WP; Gu, EW; Zhang, L; Zhu, Y | 1 |
3 other study(ies) available for sb 216763 and Alloxan Diabetes
| Article | Year |
|---|---|
Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors.
Topics: A549 Cells; Animals; Binding Sites; Catalytic Domain; Cell Survival; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Oxindoles; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship | 2019 |
Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation.
Topics: Animals; Cognition Disorders; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Indoles; Inflammation; Male; Maleimides; Neurotransmitter Agents; Nitric Oxide Synthase Type II; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2014 |
Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β.
Topics: Anesthetics, Intravenous; Animals; Blood Pressure; Blotting, Western; Cardiotonic Agents; Diabetes Mellitus, Experimental; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Heart Rate; Indoles; Male; Maleimides; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sufentanil; Troponin I | 2013 |